Traditional Chinese medicine in the treatment of breast cancer

Seminars in Oncology

Volumn 29, Issue 6, 2002, Pages 563-574

  Cohen, Isaac ^a   Tagliaferri, Mary ^a   Tripathy, Debu ^a,b,c  

^a American Acupuncture Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGI EXTRACT; ASTAGASLIA MACROCEPHALIA EXTRACT; ATRACTLODES EXTRACT; BULBUS CREAMASTRA EXTRACT; BUPLEURUM ROOT; CODONOPSIS EXTRACT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EVODIA EXTRACT; FLOS LONICERA EXTRACT; FLUOROURACIL; GANODERMA LUCIDUM EXTRACT; GINSENG EXTRACT; HERBA OLDENLADIA EXTRACT; HERBA TARAXACUM EXTRACT; HERBACEOUS AGENT; LIGUSTRI LUCIDI EXTRACT; LYCII EXTRACT; PERICARPIUM CITRUS EXTRACT; PORIA COCOS EXTRACT; RADIX ANGELICA EXTRACT; RADIX ASTRAGALUS EXTRACT; RADIX PAEONIA EXTRACT; REHMANIA EXTRACT; RHIZOMA ATRACTYLODIS EXTRACT; RHIZOMA DIOSCAREA; SALVIA MITORRHIZAE EXTRACT; SCLEROTIUM PORIA EXTRACT; SEMEN VACCARIAE EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; CHINESE HERB; CHINESE MEDICINE; HISTOPATHOLOGY; HUMAN; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRADITIONAL MEDICINE;

EID: 0036969688     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.50005     Document Type: Article

References (69)

1. Eisenberg DM, Davis RB, Ettner SL, et al: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280:1569-1575, 1998
2. Eisenberg DM, Kessler RC, Foster C, et al: Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328:246-252, 1993
3. Ernst E, Cassileth BR: The prevalence of complementary/alternative medicine in cancer. Cancer 83:777-782, 1998
4. Adler S: Complimentary and alternative medicine use among women with breast cancer. Med Anthropol Q 13:214-222, 1999
5. Jacobson JS, Workman SB, Kronenberg F: Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol 18:668-683, 2000
6. Tagliaferri M, Cohen I, Tripathy D: Complimentary and alternative medicine in early stage breast cancer. Semin Oncol 28:121-134, 2001
7. Zhang DZ: The Treatment of Cancer by Integrated Chinese Western Medicine. Boulder, CO, Blue Poppy Press, 1989, pp 1-2
8. Wu JN (trans): Ling Shu or The Spiritual Pivot. Washington, DC, The Taoist Center, 1993, p 274
9. Fu QZ (1607-1684 CE): Fu Qing Zhu's Gynecology (Yang S, Liu D, trans). Boulder, CO, Blue Poppy Press, 1992, pp 248-250
10. Zhu DX (1281-1358 CE): The Heart and Essence of Dan-xi's Methods of Treatment (Yang S, trans). Boulder, CO, Blue Poppy Press, 1993, pp 313-316
11. Zhang DZ: The Treatment of Cancer by Integrated Chinese Western Medicine. Boulder, CO, Blue Poppy Press, 1989, pp 2-13
12. Olayiwola A: WHO guidelines for the assessment of herbal medicines. ESCOP Symposium: The Scientific Assessment of Phytomedicines. Milan, Italy, March 13, 1992. Fitoterapia Vol 1, XIII, No 2, 1992
13. Balandrin, MF, Kjocke JA, Wurtele ES, et al: Natural plant chemicals: sources of industrial and medicinal materials. Science 228:1154-1160, 1985
14. O'Neil MJ, Lewis JA: The renaissance of plant research in the pharmaceutical industry, in Kinghom AD, Balandrin MF (eds): Human Medicinal Agents From Plants. ACS Symposium Series 534. Washington, DC, American Chemical Society, 1993, pp 48-55
15. Cragg GM, Newman DJ, Sander KM: Natural products in drug discovery and development. J Nat Prod 60:52-60, 1997
16. Cragg GM, Schepartz SA, Suffness M, et al: The Taxol supply crisis: New NCI policies for handling the large scale production of novel natural product anticancer and anti-HIV agents. J Nat Prod 56:1657-1668, 1993
17. Boik J: Natural Compounds in Cancer Therapy. Princeton, MN, Oregon Medical Press, 2001
18. Campbell MJ, Hamilton B, Shoemaker M, et al: Antiproliferative effects on breast cancer cells of some medicinal extracts used in traditional Chinese medicine. Proc Am Assoc Cancer Res 42:484, 2001 (abstr)
19. Shi L, Shi P: Experience in Treating Carcinoma With Traditional Chinese Medicine. Shandong, China, Shandong Science and Technology Press, 1990
20. Xie W: Cancer = Death?: Treatment of Cancer the Chinese Way. Beijing, China, New World Press, 1997
21. Cheung CS: Breast cancer supportive management: A collective works from TCM practitioners of China. San Francisco, CA, Harmonious Sunshine Press, 1999
22. Zhou M, Wu YH, Liu YD: Integrated Chinese-Westem medicine treatments for advanced stage breast cancer: An analysis of 14 cases. China Integrated Chin West Med J 15:237, 1996
23. Yin XD: An analysis of 32 cases of breast cancer treated with combination of FACT and Kang Lai Te injection. Ji Lu Tumor J 6:158-159, 1999 (in Chinese)
24. Anonymous. An analysis of 134 cases of breast cancer treated with Chinese-Westem integrated medicine. Chin Med J (Beijing) 13:111, 1985
25. Lei QM, Song JS, Fan DN et al: Observations on 77 cases of breast cancer treated with the Chinese herb Teng Huang. Cancer Prev Res 13:111, 1986 (in Chinese)
26. Yang GJ, Zhao L: Observations on the results of 216 cases of breast cancer treated with combined Chinese-Westem medicine. Intermed Med Periodical 23:48-50, 1998 (in Chinese)
27. Shen SY, Jiang CY: 14 cases of breast disease treated with a combination of Hai Zao and Gan Cao. Chinese Medical News 7:40-41, 1990 (in Chinese)
28. Wang Q, He SJ: 31 cases of breast cancer treated with integrated Chinese-Westem medicine. Cancer 9:238, 1990 (in Chinese)
29. Guo T, Xu B, Yan SQ, et al: Neoadjuvant Chemotherapy of Advanced Breast Cancer (stage III). Shandong, China, Qingdao Tumor Hospital, 2000 (in Chinese)
30. Niu DL, et al: Curative observation on effects of Chinese herbs and western drugs applied to quench vomiting caused by tumor chemotherapy. Ch J Integ Trad Chin Med West Med 15:397, 1995
31. Liu M, Yao M, Shen P: Personal Experience in Herbal Treatment of Postoperative Breast Cancer (Li PP, trans). Shanghai, China, Affiliated Longhua Hospital, Shanghai College of TCM, 1996
32. Fan C: 30 Cases of Breast Cancer Treated by Herbal Medicines During Chemotherapy After Surgery. 1996 (Li PP, trans, Beijing Medical Institute, Beijing, China)
33. Li P, Wang X, Yu R, et al: A Study of Breast Cancer Due to Mental Depression (Li PP, trans). Beijing, China, Beijing TCM Hospital, 1996
34. Liu S: Lu Deming's Experience in Treatment of Advanced Metastatic Breast Cancer. 1996 (Li PP, trans, Beijing Medical Institute, Beijing, China)
35. Ni M (trans): The Yellow Emperror's Classic of Medicine. Boston, MA, Shambhala, 1995, pp 1-4
36. Gao YT: Implications of the time trend of cancer incidence in urban Shanghai, China, for cancer. www.who.int/ncd/cancer/publications/abstracts
37. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 49:33-64, 1999
38. Greenwald P: Experience from clinical trials in cancer prevention. Ann Med 26:73-80, 1994
39. Nakachi K, Suemasu K, Suga K, et al: Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89:254-261, 1998
40. Dupont W, Page D. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
41. Haagansen CD: Diseases of the Breast (ed 2). Philadelphia, PA, Saunders, 1971
42. Chardot C, Varroy A, Parache RM: Fibro-cystic mastosis and cancer (206 cases of mastosis in possible relation with 12 cases of cancer). Bull Cancer 57:251-268, 1970
43. Roberts MM, Jones V, Elton RA, et al: Risk of breast cancer in women with history of benign disease of the breast. Br Med J (Clin Res Ed) 288:275-278, 1984
44. Bundred NJ, West RR, O'Dowd J, et al: Is there an increased risk of breast cancer in women who have a breast cyst aspirated? Br J Cancer 64:953-955, 1991
45. Bruzzi P, Dogliotti L, Naldoni C, et al: Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. Br Med J 314:925-928, 1997
46. Dixon JM, McDonald C, Elton RA, et al: Risk of breast cancer in women with palpable breast cysts: A prospective study. Edinburgh Breast Group. Lancet 353:1742-1745, 1999
47. Flaws B, Chace C: Recent TCM Research From China - 1991-1994. Boulder, CO, Blue Poppy Press, 1994, pp 86-99
48. Ye X, Zhang G: Clinical experience in the treatment of 120 cases of mammary neoplasia with ru tong ling (breast pain efficacious remedy). Tianjin J TCM 3:6, 1994
49. Tan J, Feng Y: Analysis on 96 cases of masto-hyperplasia treated by point-injection. Chin Acupuncture Moxibustion 7:27-28, 1996
50. Han J: Central neurotransmitters and acupuncture analgesia, in Pomeranz B, Stux G (eds): Scientific Basis of Acupuncture. New York, NY, Springer-Verlag, 1989, pp 7-33
51. Mandelson MT, Oestreicher N, Porter PL, et al: Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081-1087, 2000
52. Boyd NF, Byng JW, Jong RA, et al: Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675, 1995
53. Yin K: Observation on curative effect of xiao he ling applied to treat 460 patients of mastoplasia. Gansu J TCM 8:30-31, 1995
54. Li PP, Yu GQ, President Emeritus of All China Society of Cancer Prevention and Treatment With Integrated TCM and WM, personal communication, Nov 3, 1998
55. Pan M: Cancer Treatment with Fu Zheng Pei Ben Principle. Fujian, China, Fujian Science and Technology, 1992, pp 225-238
56. Yu G, Liang F, Zhang D: The combined TCM-WM prevention and treatment of malignant tumor marching towards 21 st century. International Conference on Prevention and Treatment of Cancer With TCM-WM, Nov 3-6, 1998, p 171
57. Zhang D: Preventing and treating side-effects by chemoand/or radiotherapy over the past 40 years. International Conference on Prevention and Treatment of Cancer With TCM-WM, 1998, p174
58. Liu M, Yao M, Shen P: Personal experience in herbal treatment of post-operative breast cancer. Shanghai, China, Affiliated Longhua Hospital, Shanghai College of TCM, 1991
59. Wang G, Zhao L: Observation on the results of 216 cases of breast cancer treated with integrated Chinese-Western medicine. lntermed Med Periodical [Zhong Ji Yi Kan] 23:48-50, 1988
60. Chinese Medicine Research Institute, Guang An Men Hospital Oncology Department: An analysis of 134 cases of breast cancer treated with Chinese-Western integrated medicine. Chin Med J [Zhong Yi Zha Zhi] 13:111-113, 1985
61. Yin X, Liu S, Tong J-D, et al: An analysis of 32 cases of breast cancer treated with a combination of FACT and Kang Lai Te injection. Qilu J Oncol [Qi Lu Zhong Liu Za Zhi] 6:158-159, 1999
62. Rose DP, Connolly JM, Rayburn J, et al: Influence of diets containing eicosapentaenoic acid or docosaheaenoic acid on growth and metastases of breast cancer cells in nude mice. J Natl Cancer Inst 87:587-592, 1995
63. Yang H, Wang X, Yu L, et al: Effects of Kang Lai Te (KLT) injection on cell proliferation kinetics and modulation of doxorubicin resistance. Zhejiang, China, Kang Lai Te Injection: Pharmacology and Clinical Application, Cancer Institute, Zhejiang Medical University, 1999, pp 363-366
64. Han R: Developments in research on anti-cancer Chinese herbs. China New Herbs J 2:1-7, 1993
65. Lei Q, Song Q, Fa D-N, et al: Observations on 77 cases of breast cancer treated with the Chinese herb Teng Huang. Cancer Prev Res [Zhong Liu Fang Zhi Yan Jui] 13:111, 1986
66. Vickers A, Goyal N, Harland R, et al: Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clin Trials 19:159-166, 1998
67. Tang J, Zhan S, Ernst E: Review of randomized controlled trials of traditional Chinese medicine. Br Med J 319:160-161, 1999
68. Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-92, 2001
69. Fugh-Berman A: Herb-drug interactions. Lancet 355:134-138, 2000